Latest Biodefense Stories
PathoGenetix, Inc. has delivered an early commercial version of the RESOLUTION Microbial Genotyping System to the independent contract research firm, MRIGlobal.
ANNAPOLIS, Md., April 1, 2014 /PRNewswire/ -- PharmAthene, Inc.
PRINCETON, N.J., March 26, 2014 /PRNewswire/ -- Soligenix, Inc.
BioFire Defense of Salt Lake City, Utah announced today that it was awarded the Next Generation Diagnostic System (NGDS) Technology Development contract by the US Department of Defense.
Presentation on March 25, 2014 at 2:10 PM EDT PRINCETON, N.J., March 11, 2014 /PRNewswire/ -- Soligenix, Inc.
Soligenix Initiates Medical Countermeasure Development of SGX943 PRINCETON, N.J., Feb. 14, 2014 /PRNewswire/ -- Soligenix, Inc.
Presentation to be Webcast Live on February 10, 2014 at 3 PM EST PRINCETON, N.J., Feb. 5, 2014 /PRNewswire/ -- Soligenix, Inc.
HONOLULU, Feb. 4, 2014 /PRNewswire/ -- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded Hawaii Biotech, Inc.
Receipt of Proceeds increases January Cash Position to Approximately $6.6 million PRINCETON, N.J., Jan. 16, 2014 /PRNewswire/ -- Soligenix, Inc.
Milestone Achieved under $9.4 Million NIAID Cooperative Grant PRINCETON, N.J., Jan. 15, 2014 /PRNewswire/ -- Soligenix, Inc.
- In medieval musical notation, a sign or neume denoting a shake or trill.